Uniportal VATS Versus Chest Tube for Early Empyema
- Conditions
- Empyema, Pleural
- Registration Number
- NCT06325904
- Lead Sponsor
- Minia University
- Brief Summary
This randomized controlled study compared uniportal video-assisted thoracoscopic surgery (U-VATS) versus chest tube drainage for initial (first-line) treatment of stage I (exudative) and stage II (fibrinopurulent) empyema in adult patients (\>18 years old). The primary end-point of outcome was the overall success of treatment (no need for re-intervention or death). The main results demonstrated the safety of minimally invasive U-VATS procedure in the initial treatment of early stages of pleural empyema in comparison to traditional chest tube drainage. Initial use of U-VATS was safe and feasible due to postoperative freedom from complex or marked effusion, in addition to significant reduction in the need for additional intervention, postoperative complications, length of hospital stay, and total cost.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 70
- Patients diagnosed to have empyema and indicated for surgery.
- Age above 18 years old
- Inability to tolerate single lung ventilation.
- Contraindication for general anesthesia/ medically unfit
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Mortality 6 months after inital treatment Postoperative in-hospital or follow-up death.
Need for further management 6 months after inital treatment Need for further method for pleural fluid drainage or decortication.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Minia University
🇪🇬Minya, Egypt
Minia University🇪🇬Minya, Egypt